Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba

Agents and Actions
C TouvayP Braquet

Abstract

Paf-acether appears to be a potent mediator released in response to allergen exposure in sensitized animals and it could contribute to clinical manifestations of allergic asthma. In order to ascertain this assumption the inhibition of antigen-induced lung anaphylaxis in guinea-pig by BN 52021, a new highly specific paf-acether antagonist, was studied. Ovalbumin injected into passively sensitized guinea-pig induced a large bronchoconstriction which was accompanied by thrombocytopenia and leukopenia. Treatment of animals with BN 52021 i.v., five minutes before challenge, strongly (at the doses of 1 and 2 mg/kg) or totally (at 0.1 mg/kg) inhibited the bronchoconstriction and partially reduced the thrombocytopenia and leukopenia the thrombocytopenia occurring after challenge. These results confirm that paf-acether and platelets might play a key role in asthma. BN 52021 and other paf-acether antagonist could provide a new group of potent prophylactic anti-asthma drugs.

Citations

Jun 12, 1987·European Journal of Pharmacology·J EgidoL Hernando
Aug 1, 1992·Journal of Ethnopharmacology·R J Huxtable
Jan 1, 1995·Journal of Lipid Mediators and Cell Signalling·M SaitoT Matsuda
Mar 18, 1989·Lancet
May 1, 1991·Medicinal Research Reviews·P BraquetM Koltai
Oct 22, 2008·Survey of Ophthalmology·M MozaffariehJ Flammer
Dec 31, 2011·Oriental Pharmacy and Experimental Medicine·Ravindra G Mali, Avinash S Dhake
Sep 1, 1990·JPEN. Journal of Parenteral and Enteral Nutrition·M L FoeghP W Ramwell
Dec 11, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ronan LordanConstantinos A Demopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.